215 related articles for article (PubMed ID: 4592546)
1. The use of spironolactone in the diagnosis and the treatment of hypertension associated with mineralocorticoid excess.
Beevers DG; Brown JJ; Ferriss JB; Fraser R; Lever AF; Robertson JI
Am Heart J; 1973 Sep; 86(3):404-14. PubMed ID: 4592546
[No Abstract] [Full Text] [Related]
2. Adrenal mineralocorticoids causing hypertension.
Biglieri EG; Stockigt JR; Schambelan M
Am J Med; 1972 May; 52(5):623-32. PubMed ID: 4556934
[No Abstract] [Full Text] [Related]
3. [Conn syndrome as cause of stubborn hypertension. Which hypertensives should you screen?].
Reincke M
MMW Fortschr Med; 2003 Feb; 145(9):37-40. PubMed ID: 12666528
[No Abstract] [Full Text] [Related]
4. [Hypermineralocorticoidism and hypertension].
Wolff HP; Abdelhamid S
Klin Wochenschr; 1971 Mar; 49(6):293-306. PubMed ID: 4932028
[No Abstract] [Full Text] [Related]
5. Aldosterone secretion in hypertension.
George JM; Gillespie L; Bartter FC
Ann Intern Med; 1968 Oct; 69(4):693-701. PubMed ID: 5682244
[No Abstract] [Full Text] [Related]
6. Antihypertensive effect of spironolactone in essential, renal and mineralocorticoid hypertension.
Mantero F; Armanini D; Urbani S
Clin Sci Mol Med Suppl; 1973 Aug; 45 Suppl 1():219s-24. PubMed ID: 4522169
[No Abstract] [Full Text] [Related]
7. Hypertension with aldosterone excess.
Brown JJ; Fraser R; Lever AF; Robertson JI
Br Med J; 1972 May; 2(5810):391-6. PubMed ID: 4554158
[No Abstract] [Full Text] [Related]
8. [Diagnosis of secondary hypertension causing miscarriage during the first trimester of pregnancy].
Fikri Benbrahim O; García Agudo R; Cazalla Cadenas F; Martínez Calero A; González-Spínola J
Nefrologia; 2011; 31(2):229-31. PubMed ID: 21461023
[No Abstract] [Full Text] [Related]
9. Twenty-four year spironolactone therapy in an aged patient with aldosterone-producing adenoma.
Takeda R; Yamazaki T; Ito Y; Koshida H; Morise T; Miyamori I; Hashimoto T; Morimoto S
Acta Endocrinol (Copenh); 1992 Feb; 126(2):186-90. PubMed ID: 1311894
[TBL] [Abstract][Full Text] [Related]
10. Significance of renin and angiotensin in hypertension.
Brown JJ; Fraser R; Leckie B; Lever AF; Morton JJ; Padfield PL; Semple PF; Robertson JI
Cardiovasc Clin; 1978; 9(1):55-89. PubMed ID: 352522
[No Abstract] [Full Text] [Related]
11. Pharmacological treatment of arterial hypertension.
Kokot F
Mater Med Pol; 1983; 15(3-4):131-41. PubMed ID: 6571369
[No Abstract] [Full Text] [Related]
12. Pathogenesis of mineralocorticoid hypertension.
Schalekamp MA; Wenting GJ; Man in 't Veld AJ
Clin Endocrinol Metab; 1981 Nov; 10(3):397-418. PubMed ID: 7047017
[No Abstract] [Full Text] [Related]
13. The diagnostic and therapeutic value of spironolactone in patients with systemic hypertension.
Burden RP; Booth LJ; Aber GM
Nephron; 1973; 9(3):171-88. PubMed ID: 4682245
[No Abstract] [Full Text] [Related]
14. Sodium and the renin-angiotensin system in essential hypertension and mineralocorticoid excess.
Lebel M; Schalekamp MA; Beevers DG; Brown JJ; Davies DL; Fraser R; Kremer D; Lever AF; Morton JJ; Robertson JI; Tree M; Wilson A
Lancet; 1974 Aug; 2(7876):308-9. PubMed ID: 4136047
[No Abstract] [Full Text] [Related]
15. [Primay hyperaldosteronism--diagnostic and treatment].
Potthoff SA; Beuschlein F; Vonend O
Dtsch Med Wochenschr; 2012 Nov; 137(48):2480-4. PubMed ID: 23168980
[TBL] [Abstract][Full Text] [Related]
16. Hypertension and low plasma renin activity: presumptive evidence for mineralocorticoid excess.
Spark RF; Melby JC
Ann Intern Med; 1971 Dec; 75(6):831-6. PubMed ID: 5134893
[No Abstract] [Full Text] [Related]
17. Primary aldosteronism: the most frequent form of secondary hypertension?
Shargorodsky M; Zimlichman R
Isr Med Assoc J; 2002 Jan; 4(1):32-3. PubMed ID: 11802308
[No Abstract] [Full Text] [Related]
18. Therapeutic alternatives in hypertension.
Brest AN; Ruggiero N
Chest; 1973 Oct; 64(4):491-4. PubMed ID: 4598147
[No Abstract] [Full Text] [Related]
19. Effect of spironolactone in hypertensive patients.
Crane MG; Harris JJ
Am J Med Sci; 1970 Dec; 260(6):311-30. PubMed ID: 5511395
[No Abstract] [Full Text] [Related]
20. Normokalemic hyperaldosteronism in patients with resistant hypertension.
Benchetrit S; Bernheim J; Podjarny E
Isr Med Assoc J; 2002 Jan; 4(1):17-20. PubMed ID: 11802302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
